Search PubMed⌕ Search

Biomedical subjects

H Yonas

Publications and source records attributed to H Yonas.

178 records · Page 10Linked to original sources
PubMedDate not supplied

Xenon and iodine enhanced cerebral CT: A closer look.

Xenon and iodine enhanced dynamic computerized tomography (CT) have been used experimentally to obtain both qualitative and quantitative information on local cerebral blood flow in both normal and infarcted tissue. Direct comparisons between Xenon enhancement, iodine enhancement and pathological findings demonstrate significant differences between results derived from each of the 2 in vivo techniques. While iodine enhanced dynamic CT yields valuable information concerning the patency and density of vasculature, xenon enhanced studies can provide highly focal information on cerebral tissue perfusion.

Animals↗
PubMedDate not supplied

Progress in cerebrovascular disease: local cerebral blood flow by xenon enhanced CT.

A noninvasive technique for measuring local cerebral blood flow (LCBF) by xenon enhanced x-ray transmission computed tomography (CT) has been developed an reported quite extensively in recent years. In this method, nonradioactive xenon gas in inhaled and the temporal changes in radiographic enhancement produced by the inhalation are measured by sequential computed tomography. Time dependent xenon concentrations within various tissue segments in the brain are used to derive both local partition coefficient (lambda) and LCBF. An assessment of this method reveals that although it provides functional mapping of blood flow with excellent anatomic specificity, there are distinct limitations. The assumptions underlying this methodology are examined and problems associated with various potential applications of this technique are discussed.

Animals↗
PubMedDate not supplied

Clinical experience with the use of xenon-enhanced CT blood flow mapping in cerebral vascular disease.

Cerebral blood flow mapping with the xenon-enhanced/CT method has become a useful clinical tool in the management of patients with occlusive cerebral vascular disease. Studies involving 4-5 minutes of inhaling a xenon/oxygen mixture (less than or equal to 35%) can now be performed routinely with acceptable patient tolerance and compliance. Four cases with acute and chronic ischemic injuries are reported here to illustrate the manner in which this method has been used to characterize flow pattern in such patients and the relevance of this flow information to clinical patient management.

Adult↗
PubMedDate not supplied

Measurement of cerebral blood flow during xenon inhalation as measured by the microspheres method.

Measurements of cerebral blood flow (CBF) were performed using the microsphere technique in non-human primates (baboons) to assess the effect of non-radioactive xenon gas inhalation on CBF. Blood flows in small tissue volumes (approximately 1 cm3) were directly measured before and during the inhalation of xenon/oxygen gas mixtures. The results of these studies demonstrated that when inhaled in relatively high concentrations, xenon gas does increase CBF, but the changes are more global than tissue-specific. The problems and limitations of such evaluations are discussed.

Animals↗
PubMedDate not supplied

Xe/CT cerebral blood flow evaluation of delayed symptomatic cerebral ischemia after subarachnoid hemorrhage.

PURPOSE: We examined the xenon/CT method of measuring cerebral blood flow in assessing the location, pattern of onset, and severity of delayed cerebral ischemia. PATIENTS AND METHODS: Fourteen patients with delayed neurologic deficits due to ischemia were selected from a group of 66 patients with subarachnoid hemorrhage. All blood flow studies were performed within 12 hours of deterioration and at regular intervals during medical management. RESULTS: In 10 of the 14 patients, noncontrast CT did not identify a cause for deterioration, whereas the blood flow study revealed diminished flow values. Location of blood flow reduction was variable. In five of the 14 patients, blood flow reduction was closely related anatomically to the vessel of aneurysm origin. In another three, blood flow reduction was anatomically remote to the vessel of origin. The remaining six experienced local and remote cerebral blood flow reduction. Six of 14 patients suffered sudden, devastating deterioration, refractory to therapy and associated with blood flow of 15 cc/100 g.min or less, resulting in local or widespread infarction. The remaining eight had less severe blood flow reduction and did not infarct those territories. CONCLUSIONS: Vasospasm can affect remote vessels as severely as local vessels and can affect remote vessels alone. Diminished cerebral blood flow correlated closely with clinical vasospasm in this group of patients. Xenon/CT cerebral blood flow studies can identify tissue at risk of infarction when CT is normal.

Adult↗
PubMedDate not supplied

The role of xenon CT measurements of cerebral blood flow in the clinical determination of brain death.

The demonstration of absent blood flow to the brain is often used as a confirmatory test of brain death. Traditionally, cerebral angiography and dynamic radionuclide brain scanning have been used for this purpose. Recently, xenon CT cerebral blood flow techniques have been developed and applied to a wide variety of clinical problems, including the confirmation of brain death. We report our experience with xenon CT studies performed over a 7-year period (1983-1989) in 30 patients with brain injuries. These patients met clinical criteria for brain death within 24 hr of the study. Twenty patients had average global flow values of less than 5 ml/100 ml/min. Seven patients demonstrated mixed flow patterns, whereby large areas of brain showed flow values of less than 5 ml/100 ml/min and residual pockets of flow greater than 5 ml/100/ml/min. Globally symmetric normal to hyperemic flows were seen in three patients. Our study suggests that the demonstration of average global flows of less than 5/ml/100 ml/min is confirmatory of brain death. Demonstration of persistent flow to the entire brain or regions of the brain is not diagnostic of brain death but also does not exclude such an outcome in patients with severe brain injuries. Xenon-derived flow information may be clinically useful in determining the patient's prognosis and in counseling the patient's family.

Adolescent↗
PubMedDate not supplied

Stable xenon CT cerebral blood flow imaging: rationale for and role in clinical decision making.

The stable xenon CT method of measuring cerebral blood flow has been investigated in research studies for over 10 years. Recently, it has been gaining clinical acceptance, primarily owing to a combination of several unique advantages it holds over other cerebral blood flow measurement techniques. The accuracy of this technique in quantifying low cerebral blood flow gives it a unique application in cases of brain death and acute stroke and it can be repeated after an interval of 20 min. making it possible to evaluate autoregulation and cerebrovascular reserve. Furthermore, cerebral blood flow information is directly coupled to CT anatomy. Although it is more difficult to administer than a standard CT scan, careful monitoring can ensure patient safety during the examination. In this article we review the physiologic and technical bases for the clinical application of xenon CT-derived quantitative cerebral blood flow information and discuss the advantages and disadvantages of the technique. We also describe its current clinical applications, including its usefulness in the evaluation of acute stroke, occlusive vascular disease, carotid occlusion testing, vasospasm, arteriovenous malformations, and head trauma management.

Cerebrovascular Circulation↗
PubMedDate not supplied

Impaired cerebral vasoreactivity after embolization of arteriovenous malformations: assessment with serial acetazolamide challenge xenon CT.

Embolization of a portion of the nidus of an arteriovenous malformation not only may alter hemodynamics within the nidus, but also may change blood flow dynamics in adjacent normal vessels. Sequential acetazolamide-challenge xenon CT cerebral blood flow studies were performed in eight patients before and after embolization of arteriovenous malformations to assess the hemodynamic effects on the major vascular territories supplying the malformation. Acetazolamide is a potent cerebral vasodilator, and its administration combined with cerebral blood flow studies allows assessment of cerebral vasoreactivity. In seven of the eight patients, one or more parenchymal areas exhibited a normal cerebral blood flow augmentation response to acetazolamide before embolization, but diminished acetazolamide flow augmentation was seen after embolization, indicating abnormal vasoreactivity. We found that the decrease in vasoreactivity peaked 6-10 days after embolization. In one of the eight patients, a temporary delayed neurologic deficit developed during a period of impaired cerebral vasoreactivity following embolization. Our results suggest that embolization of an arteriovenous malformation can induce vasoreactivity changes in adjacent normal vessels. Because these changes appear to be somewhat time-dependent, an appropriate interval should be observed between embolization stages or before surgical resection of an arteriovenous malformation following embolization to allow hemodynamic equilibration to occur. Acetazolamide challenge combined with serial cerebral blood flow studies following embolization enables determination of this hemodynamic equilibration.

Acetazolamide↗
PubMedDate not supplied

Balloon test occlusion of the internal carotid artery with stable xenon/CT cerebral blood flow imaging.

We describe a technique to predict preoperatively the safety of permanently occluding an internal carotid artery. The method was performed by imaging stable xenon cerebral blood flow (CBF) with the internal carotid artery both open and temporarily occluded with a nondetachable balloon on a double lumen Swan-Ganz catheter. Patients were those in whom we planned to sacrifice the internal carotid artery (those with giant or inaccessible aneurysms) or those in whom such a sacrifice was at least likely (those with skull base tumors). Patients were divided into three groups on the basis of a comparison of occluded and nonoccluded CBF values. Group-I patients had no significant change in CBF with internal carotid artery occlusion; group-II patients showed a symmetric decrease in CBF; and group-III patients had an asymmetric decrease in CBF, always greater on the occluded side. A fourth group clinically failed to tolerate even brief carotid occlusion. The internal carotid artery in one patients from group III was sacrificed at surgery: the size and shape of his postoperative infarct corresponded almost exactly to the area of asymmetrically decreased CBF on his occluded study. The data suggest that if surgery is likely to result in permanent occlusion of the internal carotid artery, then patients who are at risk for delayed neurologic injury due to a compromised cerebral blood flow should have arterial bypass grafts before such surgery is performed.

Brain Ischemia↗
PubMedDate not supplied

Xenon/CT cerebral blood flow studies during continuous depth electrode monitoring in epilepsy patients.

PURPOSE: To observe and describe cerebral blood flow (CBF) alterations immediately following depth electrode stimulation of the temporal lobe in patients with medically intractable epilepsy. MATERIALS AND METHODS: Five patients with partial epilepsy undergoing presurgical evaluation were chosen for xenon/CT cerebral blood flow (Xe/CT CBF) measurement immediately following electrically stimulated seizures via stereotactically placed temporal lobe depth electrodes. Each patient had a baseline Xe/CT CBF study. Four of the five patients had a total of seven temporal lobe stimulations each followed by a Xe/CT CBF study. The other patient had right temporal lobe electrical status epilepticus and was scanned without stimulation or electroencephalogram monitoring. RESULTS: Of the four baseline or interictal scans, no areas of abnormally low flow were detected, but one baseline scan had elevated flows of 115 mL.100 g-1.min-1 in the left temporal lobe. One stimulation elicited 8 seconds of afterdischarge potentials, but no alteration of CBF was detected. One stimulation elicited an aura but no electrographic seizure was detected. This resulted, however, in bitemporal lobe elevation of CBF. The other five temporal lobe stimulations resulted in 17-63 seconds of afterdischarge potentials and all resulted in elevation of CBF to 69-118 mL.100 g-1.min-1. One of these five stimulations resulted in seizure and localized elevation of CBF. Following seizure activity, elevated CBF began to return to baseline levels by 20 minutes. CONCLUSION: This study reveals a direct spatial and temporal relationship of elevated CBF with seizures. This study provides the most direct data to date in human subjects that focal seizure activity elevates CBF. Since seizures are known to increase metabolic activity in the activated tissue, this data also supports the assumption of coupling between CBF and metabolism during the pathologic process of a seizure.

Adult↗
PubMedDate not supplied

Reversible ischemia determined by xenon-enhanced CT after 90 minutes of complete basilar artery occlusion.

Intraarterial thrombolytic therapy decreases mortality in the treatment of acute basilar artery occlusion. An acute decrease in cerebral blood flow (CBF) (<12 mL/100 g per minute) has been reported to invariably result in infarction. We report a case of acute basilar artery occlusion, recanalized within 90 minutes, with reversal of CBF of less than 6 mL/100 g per minute. After reperfusion, areas with persistent CBF of 6 mL/100 g per minute resulted in infarctions on subsequent CT studies. Parenchymal viability is possible after 90 minutes of posterior CBF of 6 mL/100 g per minute.

Acute Disease↗